CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 139 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $214,000 | +89.4% | 5,562 | +14.4% | 0.00% | – |
| Q1 2023 | $113,000 | -46.2% | 4,860 | -39.5% | 0.00% | – |
| Q4 2022 | $210,000 | +775.0% | 8,036 | +558.7% | 0.00% | – |
| Q3 2022 | $24,000 | +500.0% | 1,220 | +393.9% | 0.00% | – |
| Q2 2022 | $4,000 | -90.2% | 247 | -90.0% | 0.00% | – |
| Q1 2022 | $41,000 | -66.4% | 2,478 | -66.8% | 0.00% | – |
| Q4 2021 | $122,000 | +212.8% | 7,474 | +143.9% | 0.00% | – |
| Q3 2021 | $39,000 | +30.0% | 3,064 | +40.4% | 0.00% | – |
| Q2 2021 | $30,000 | +172.7% | 2,182 | +193.7% | 0.00% | – |
| Q1 2021 | $11,000 | – | 743 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |